Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals. [electronic resource]
Producer: 20120920Description: 444-8 p. digitalISSN:- 1879-1484
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Biomarkers -- blood
- Blood Pressure -- drug effects
- Brazil
- Chi-Square Distribution
- Cholesterol -- blood
- Diastole -- drug effects
- Diuretics -- therapeutic use
- Double-Blind Method
- Drug Therapy, Combination
- Echocardiography, Doppler
- Enalapril -- therapeutic use
- Female
- Humans
- Hydrochlorothiazide -- therapeutic use
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypertension -- blood
- Male
- Middle Aged
- Prospective Studies
- Regression Analysis
- Simvastatin -- therapeutic use
- Stroke Volume -- drug effects
- Time Factors
- Treatment Outcome
- Ventricular Dysfunction, Left -- blood
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.